Results 31 to 40 of about 277 (133)
Taiwan Journal of OphthalmologyPlaque brachytherapy plays an essential role in the management of intraocular tumors, allowing localized treatment while minimizing damage to surrounding structures. Since the earliest reports of sutured radon seeds used in glioma treatment in the 1920s,
Joshua Lim +4 more
doaj +1 more source
Indian Journal of Ophthalmology, 2012 Context: To analyze the results of episcleral plaque brachytherapy using indigenous Bhabha Atomic Research Centre (BARC) Iodine-125 Ocu-Prosta seeds for the management of intraocular tumors from a single institute.
Parag K Shah +6 more
doaj +1 more source
Advanced Engineering Materials, Volume 28, Issue 6, 18 March 2026.This study demonstrates a novel noninvasive strategy to treat in‐stent restenosis using focused ultrasound. A shape memory alloy stent initially expands at body temperature. If restenosis occurs, targeted ultrasound heating thermally actuates the stent, enabling a secondary expansion to reopen the blocked vessel, offering a potential alternative to ...
Stephen Asare +3 more
wiley +1 more source
Plaque Brachytherapy for DICER1-Associated Ciliary Body Medulloepithelioma
Journal of Current OphthalmologyPurpose: To report the outcome of a ciliary body medulloepithelioma associated with DICER-1 syndrome treated with iodine-125 plaque brachytherapy. Methods: An 11-year-old male with a DICER1 gene mutation, who was previously treated for pineoblastoma with
Mojtaba Abrishami +2 more
doaj +1 more source
Indian Journal of Ophthalmology, 2019 In this case report, we demonstrate the use of optical coherence tomography angiography (OCTA) as a tool to evaluate intrinsic vasculature in a case of juxtapapillary melanoma which underwent ruthinium.106 plaque brachytherapy.
P Mahesh Shanmugam +5 more
doaj +1 more source
American Journal of Ophthalmology Case Reports, 2022 Purpose: To describe the management of submacular hemorrhage (SMH), a vision threatening complication following transvitreal choroidal biopsy, with intravitreal tissue plasminogen activator (tPA) and pure perfluoropropane (C3F8) gas bubble injection ...
Ramsudha Narala +2 more
doaj +1 more source
Forty-year prognosis after plaque brachytherapy of uveal melanoma [PDF]
Scientific Reports, 2020 AbstractIn this study, the long-term patient survival after plaque brachytherapy of uveal melanoma is examined. All patients treated between 1980 and 1999 at a single institution were included (n = 677). 533 (79%) had deceased before the end of follow-up. The median follow-up for the 144 survivors was 25.4 years (SD 5.2).
openaire +3 more sources
Journal of Applied Clinical Medical Physics, Volume 27, Issue 3, March 2026.Abstract Purpose To develop and implement an in‑house treatment‑management platform to improve communication, data accessibility, and task tracking across a radiation oncology department. Methods We developed Capsule, a custom software platform that centralizes patient data from the ARIA oncology information system (Varian Medical Systems, Palo Alto ...
Grace N. Chang +8 more
wiley +1 more source
Journal of Applied Clinical Medical Physics, Volume 27, Issue 3, March 2026.Abstract Background and purpose Stereotactic radiosurgery/radiotherapy (SRS/SRT) has emerged as a less invasive alternative to enucleation in the management of ocular malignancies. SRS/SRT planning is time‐consuming, complex, and the plan quality depends on the experience of the treatment planner.
Chase Cochran +3 more
wiley +1 more source
Medical Physics, Volume 53, Issue 3, March 2026.Abstract Background Ruthenium‐106 (Ru‐106) plaque brachytherapy is an established treatment modality for choroidal melanoma that delivers localized beta radiation while sparing surrounding ocular structures. It is widely used in Europe and parts of Asia, whereas COMS Iodine‐125 and Palladium‐103 plaques remain the standard in the United States. However,
Jin Dong Cho +5 more
wiley +1 more source